CorrespondenceAffordable Prescription DrugsBilling/TransparencyEmergency PreparednessFederal AdvocacyMedical LiabilityRegulatory AdvocacyTelehealth Advocacy Correspondence: CMS Comment Letter, OPPS and ASC Proposed Rule, CY 2022 Revised 9/17/2021
CorrespondenceBehavioral HealthFederal AdvocacyMedicareTelehealthWorkforce Advocacy Correspondence: CMS Comment Letter, Physician Fee Schedule Proposed Rule CY 2022 Revised 9/13/2021
CorrespondenceFederal Advocacy Advocacy Correspondence: HAP Comment Letter to CMS, Medicare Hospital IPPS Proposed Rule FFY 2022 Revised 6/28/2021
CorrespondenceFederal Advocacy Advocacy Correspondence: Comments to CMS, Review Choice Demonstration for IRF Services Revised 2/16/2021
Fact Sheets and InfographicsAccess to CareAffordable Prescription DrugsBehavioral HealthEmergency PreparednessFederal AdvocacyLicensurePopulation HealthRegulatory AdvocacyState AdvocacyTelehealthWorkforce 2021–2022 State and Federal Legislative Advocacy Agenda Revised 12/11/2020